000 | 01898 a2200493 4500 | ||
---|---|---|---|
005 | 20250515112539.0 | ||
264 | 0 | _c20080417 | |
008 | 200804s 0 0 spa d | ||
022 | _a0034-9356 | ||
024 | 7 |
_a10.1016/s0034-9356(08)70495-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHernández, A | |
245 | 0 | 0 |
_a[Is morphine still the analgesic of choice in acute myocardial infarction?]. _h[electronic resource] |
260 |
_bRevista espanola de anestesiologia y reanimacion _cJan 2008 |
||
300 |
_a32-9 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAmerican Heart Association |
650 | 0 | 4 |
_aAnalgesics, Opioid _xadverse effects |
650 | 0 | 4 |
_aAngina Pectoris _xdrug therapy |
650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
650 | 0 | 4 |
_aEndothelins _xmetabolism |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aMorphine _xadverse effects |
650 | 0 | 4 |
_aMulticenter Studies as Topic _xstatistics & numerical data |
650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitroglycerin _xtherapeutic use |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 |
_aReceptors, Opioid, mu _xagonists |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xphysiology |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aSola, M A | |
700 | 1 | _aDomínguez, B | |
700 | 1 | _aRochera, M I | |
700 | 1 | _aBascuñana, P | |
700 | 1 | _aGancedo, V | |
773 | 0 |
_tRevista espanola de anestesiologia y reanimacion _gvol. 55 _gno. 1 _gp. 32-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0034-9356(08)70495-x _zAvailable from publisher's website |
999 |
_c17835369 _d17835369 |